No Detail Found!

Fibroscan compared to aspartate aminotransferase to platelet ratio index (apri) and aspartate aminotransferase to alanine aminotransferase ratio (ast to alt) in the assessment of liver fibrosis in patients with non alcoholic fatty liver disease in a tertiary care hospital

Author(s)
Hasan Ikram Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Syed Raza Jaffar Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS), Rawalpindi, Pakistan
Asma Hayat Combined Military Hospital Jehlum/National University of Medical Sciences (NUMS), Pakistan
Mehnaz Khattak Fauji Foundation Hospital Rawalpindi, Pakistan,
Nauman Majeed The Indus Hospital Karachi, Pakistan, Army Medical College/ National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Afnan Naeem Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objectives: To compare the extent of liver fibrosis using fibroscan and subsequently compare it with AST/ALT ratio and AST to platelet ratio index (APRI). Study Design: Comparative cross-sectional study. Place and Duration of Study: Chemical Pathology Department, Pak Emirates Military Hospital Rawalpindi in collaboration with Armed Forces Institute of Radiology & Imaging and Gastroenterology Department, Pak Emirates Military Hospital Rawalpindi Pakistan, from Jan to Apr 2021. Methodology: A total of 50 patients in group-1 and 24 healthy subject participants in group-2 as controls were studied. Serum AST, ALT, platelet count, APRI and AST to ALT ratio were assessed along with fibroscan results to determine stages of liver fibrosis and results were compared for the association. Results: There were 49 (66%) males and 25 (34%) females included in the study with the mean age of 49.77 ± 8.3 years. 11 (14.9%) patients had advanced fibrosis. There was a significant negative relationship (p-value <0.001 and r=-0.637) between platelet count and increasing fibroscan score (F1, F2) and a significant positive correlation between fibroscan score and AST (p-value <0.001 and r=0.623), ALT (p-value <0.001 and r=0.596), fibroscan result and APRI (p-value <0.001 and r=0.771) and fibroscan scores and AST/ALT ratio (p-value= 0.037 and r=0.243). One third of the study subjects had fibrosis in early and relatively advanced stages (F1, F2 respectively) correlating with serum and blood markers. Conclusion: Early fibro scan testing and serum markers can help in early diagnosis and timely initiation of treatment.
Publication Details
Page(s) 676-680
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 72, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
APRI, Non-Alcoholic Fatty Liver Disease (NAFLD), AST/ALT ratio (DeRitis ratio), Transient elastography.
0

Citations

0

Downloads

151

Views